Literature DB >> 15673812

Pulmonary hypertension.

Paul McLoughlin, Jean-Marc Hyvelin, Katherine Howell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15673812     DOI： 10.1056/NEJM200501273520421

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension.

Authors:  David J Ross; Greg Hough; Susan Hama; Jamil Aboulhosn; John A Belperio; Rajan Saggar; Brian J Van Lenten; Abbas Ardehali; Mansoureh Eghbali; Srinivasa Reddy; Alan M Fogelman; Mohamad Navab
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

2.  Pulmonary hypertension: diagnosis and management.

Authors:  Michael D McGoon; Garvan C Kane
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

Review 3.  An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension.

Authors:  Weifang Zhang; Zeying Tao; Fei Xu; Qian Diao; Juan Li; Lu Zhou; Yaxin Miao; Shanshan Xie; Jinjin Wan; Ruilai Xu
Journal:  Biomed Res Int       Date:  2021-10-07       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.